These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 27997902
1. Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein. Lin X, Bai F, Nie J, Lu S, Lu C, Zhu X, Wei J, Lu Z, Huang Q. Cell Physiol Biochem; 2016; 40(6):1422-1432. PubMed ID: 27997902 [Abstract] [Full Text] [Related]
2. Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells. Wei J, Huang Q, Bai F, Lin J, Nie J, Lu S, Lu C, Huang R, Lu Z, Lin X. Chem Biol Interact; 2017 Jan 05; 261():118-126. PubMed ID: 27899290 [Abstract] [Full Text] [Related]
3. Raf Kinase Inhibitory Protein Down-Expression Exacerbates Hepatic Fibrosis In Vivo and In Vitro. Huang Q, Liang C, Wei L, Nie J, Lu S, Lu C, Zhuo L, Lu Z, Lin X. Cell Physiol Biochem; 2016 Jan 05; 40(1-2):49-61. PubMed ID: 27842313 [Abstract] [Full Text] [Related]
4. Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression. Huang Q, Bai F, Nie J, Lu S, Lu C, Zhu X, Zhuo L, Lin X. Int Immunopharmacol; 2017 Jan 05; 42():130-138. PubMed ID: 27912149 [Abstract] [Full Text] [Related]
5. Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice. Feng Z, Pang L, Chen S, Pang X, Huang Y, Qiao Q, Wang Y, Vonglorkham S, Huang Q, Lin X, Wei J. Int Immunopharmacol; 2020 Nov 05; 88():107003. PubMed ID: 33182043 [Abstract] [Full Text] [Related]
7. Loss of Raf kinase inhibitor protein is associated with malignant progression in hepatic fibrosis. Huang Q, Wei L, Liang C, Nie J, Lu S, Lu C, Tan S, Lv S, Zhuo L, Lu Z, Lin X. Biomed Pharmacother; 2016 Aug 05; 82():669-76. PubMed ID: 27470410 [Abstract] [Full Text] [Related]
9. Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma. Singhal J, Nagaprashantha LD, Vatsyayan R, Ashutosh, Awasthi S, Singhal SS. Cancer Prev Res (Phila); 2012 Mar 05; 5(3):473-83. PubMed ID: 22174364 [Abstract] [Full Text] [Related]
10. Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways. Peng R, Wang S, Wang R, Wang Y, Wu Y, Yuan Y. Discov Med; 2017 Feb 05; 23(125):81-94. PubMed ID: 28371611 [Abstract] [Full Text] [Related]
11. Yu Gan Long Ameliorates Hepatic Fibrosis by Inhibiting PI3K/AKT, Ras/ERK and JAK1/STAT3 Signaling Pathways in CCl4-induced Liver Fibrosis Rats. Li HG, You PT, Xia Y, Cai Y, Tu YJ, Wang MH, Song WC, Quan TM, Ren HY, Liu YW, Dan HX, Xu SQ. Curr Med Sci; 2020 Jun 05; 40(3):539-547. PubMed ID: 32681257 [Abstract] [Full Text] [Related]